before today I thought that the next 5 patients in Georgia might be a catalyst for SP movement. I still think so. These implants are carried out under FDA standards by US top specialists. If the next 5 results reflect the first it will prove that we have a world class product. The FDA trial will be important but the Majors will be satisfied that the FIH 10s outstanding results will be replicated in the US study. If I was a Major company I would make a generous take over offer early provided that the FDA results replicate the Georgian ones. If not nothing lost , if replicated they would be in the box seat.
before today I thought that the next 5 patients in Georgia might...
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$11.50 |
Change
0.070(0.61%) |
Mkt cap ! $243.1M | |||
| Open | High | Low | Value | Volume |
| $11.45 | $11.50 | $11.32 | $90.21K | 7.885K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 53 | $11.26 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $11.50 | 2061 | 1 |
View Market Depth
| Last trade - 16.10pm 15/10/2024 (20 minute delay) ? |
| AVR (ASX) Chart |